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1. Introduction  
There is a need for mammalian cell cryopreservation methods that either avoid or improve 
upon outcomes employing dimethyl sulfoxide (DMSO) as a cryoprotectant. DMSO was the 
second effective cryoprotectant to be discovered (Lovelock, 1959). Cell cryopreservation 
usually involves slow rate freezing with DMSO in culture medium and storage below -135°C 
for later use. Typically as long as there are enough cells surviving to start an expanding 
proliferating culture the yield of viable cells after thawing is not an important consideration. 
However, there are instances where cell yield and viability can be very important. Examples 
include minimization of expensive delays when starting cultures for bioreactor protein 
manufacturing runs and cellular therapies that involve administering cells into patients for 
treatment of various diseases, such as cancer. While some cells, for example fibroblasts, are 
easily cryopreserved other cell types like keratinocytes, hepatocytes, and cardiac myocytes do 
not freeze well and cell yields are often <50%. Furthermore, current opinion is that DMSO 
should be removed before cells are infused into patients (Caselli et al., 2009; Junior et al., 2008; 
Mueller et al., 2007; Otrock et al., 2008; Schlegel et al., 2009). The mechanism for DMSO 
cytotoxicity has not been determined, however, it is thought to modify membrane fluidity, 
induce cell differentiation, cause cytoplasmic microtubule changes and metal complexes 
(Barnett 1978; Katsuda et al., 1984, 1987; Miranda et al., 1978). DMSO also decreases expression 
of collagen mRNAs in a dose-dependent manner (Zeng et al., 2010).  
One strategy for finding interesting new cryoprotectants and cryopreservation strategies is 
by evaluating what happens in nature (Brockbank et al., 2011). No examples of organisms 
synthesizing DMSO to survive freezing conditions have been found to date, however 
several creatures have been found that employ glycerol (Brockbank et al., 2011) the first 
effective cryoprotectant to be discovered (Polge, 1949). Nature has developed a wide variety 
of organisms and animals that tolerate low temperatures and dehydration stress by 
accumulation of large amounts of disaccharides, particularly trehalose, including plant 
seeds, bacteria, insects, yeast, brine shrimp, fungi and their spores, cysts of certain 
crustaceans, and some soil-dwelling animals. While the cryoprotective capabilities of 
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sucrose and trehalose has been known for years, conventional cryopreservation protocols 
have generally not employed them even though early work with them demonstrated their 
ability to protect proteins and membrane vesicles during freezing (Rudolf & Crowe, 1985; 
Crowe et al., 1990). Trehalose has both major advantages and disadvantages for potential 
preservation of mammalian cells. On the negative side mammalian cells do not have an 
active trehalose transport system for uptake of trehalose from the extracellular environment, 
while on the plus side if you can get it in mammalian cells it is not metabolized giving the 
opportunity for trehalose to be accumulated to potentially effective preservation 
concentrations. The purpose of the studies presented here were; 1) to assess or review 
alternative strategies for delivery of trehalose into mammalian cells, and; 2) to determine 
whether the benefits were specific to trehalose by investigating alternative sugars 
employing the same loading strategies. 
2. Materials and methods 
2.1 Cell culture 
Cells used in these studies are described in Table 1. All were grown and maintained at 37oC 
in 5% carbon dioxide.  
 
Description Acronym Culture conditions 
Rat aortic myofibroblast cells 
A10 
(ATCC# CRL-
1476) 
DMEM* (4.5 g/L) 
10% FCS 
1.0 mM sodium pyruvate 
Bovine calf pulmonary artery endothelial 
cells 
CPAE 
(ATCC# CCL-209) 
EMEM** 
10% FCS 
1 mM sodium pyruvate 
2 mM glutamine 
1X non-essential amino 
acids 
Rat aortic smooth muscle cells 
A7R5 
(ATCC# CRL-
1444) 
DMEM (4.5 g/L) 
10% FCS 
1.0 mM sodium pyruvate 
Bovine corneal endothelial cells 
BCE 
(ATCC# CRL-
2048) 
DMEM (4.5 g/L) 
10% FCS 
1 mM sodium pyruvate 
4 mM glutamine 
*Dulbecco’s Modified Eagle’s Medium 
**Eagle’s Minimum Essential Medium 
Table 1. Cell types  
2.2 Cell poration with H5 
The pore-forming protein H5 was obtained from the lab of Hagan Bayley  (Bayley, 1994). It 
is derived from the bacterial toxin ǂ-hemolysin, which forms constitutively opened pores in 
cell membranes. The modified bacterial toxin has been engineered to form pores in the 
membrane that can be opened and closed by the addition of Zn+. More specific details are 
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presented in the discussion. Cells were plated at 10,000-20,000 cells/well the night before in 
96 well microtiter plates. The next day, the cells were washed with DMEM containing 1 mM 
EDTA for 2 minutes and then again with DMEM to remove the EDTA. 0.2M trehalose was 
added and incubated for 20 minutes at 37oC followed by the appropriate concentration of 
H5 for the respective cell type. Cells were porated and loaded with trehalose for 1 hour at 
37oC before addition of DMEM with 25 µM ZnSO4 or 10% serum to close the pores. 
Trehalose in DMEM was then added to the wells followed by cryopreservation using a 
controlled rate freezer (Planar) at ~-1.0oC/min from 4ºC to -80ºC with a programmed 
nucleation step at -5.0oC. Cryopreserved cells were stored overnight at <-135oC. The next 
day, the cells were placed at -20oC for 30 minutes followed by rapid thawing at 37oC 
(Campbell et al., 2003; Taylor et al., 2001). The cell cultures were washed twice and then 
placed at 37oC for 1 hour to recover under normothermic cell culture conditions before 
assessment of cell viability. 
2.3 Pretreatment (Incubation) with trehalose 
Cells were plated at 10,000-20,000 cells/well and placed in culture. The next day, the culture 
medium was replaced with EMEM or DMEM containing trehalose (0-0.6M) and cultured at 
37oC for varying periods of time. After culture, the solution was replaced with fresh 
medium containing trehalose (0-0.6M) and the cells were cryopreserved using a controlled 
rate freezer as described for H5 above.  
2.4 Cell poration with ATP 
Cells were plated at 10,000-20,000 cells/well and placed in culture. The next day, the cells 
were washed with poration buffer (phosphate-buffered saline [PBS] with 1X essential amino 
acids, 1X Vitastock, 5.5 mM glucose) designed to optimize binding of ATP4- to the receptor 
and facilitate formation of the pore. The cells were then placed in 50 µl poration buffer, pH 
of 7.45, with 0.2M trehalose. A stock solution of 100 mM ATP4-, pH of 7.45, was made fresh 
and added to each well to achieve a final concentration of 5 mM. After addition of the ATP4-, 
the cells were left at 37oC for 1 hour to allow sugar uptake. Following incubation, 200 µl of 
DMEM plus 1 mM MgCl2 was then added to the cells at 37oC to close the pores. After 1 hour 
of recovery from the loading procedure cryopreservation was initiated. 
2.5 Assessment of cell viability 
Cell viability was determined using the non-invasive metabolic indicator alamarBlue™ 
(Trek Diagnostics). A volume of 20 µl was added to cells in 200 µl of DMEM (10%FCS) and 
the plate was incubated at 37oC for 3 hours. Plates were read using a fluorescent microplate 
reader (Molecular Dynamics) at an excitation wavelength of 544 nm and an emission 
wavelength of 590 nm. Viability was measured before and after sugar loading, immediately 
after thawing and at several later time points post-thaw. 
2.6 Statistical methods 
All experiments were repeated at least four times with four replicates in each experiment. 
Statistical differences were assessed by two way analysis of variance.  P-values 0.05 were 
regarded as significant.  
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3. Results 
3.1 H5 poration 
One of the first strategies for utilizing disaccharide sugars as cryoprotectants involved the use 
of a modified pore forming complex. In our initial studies we evaluated the H5 mutant ǂ-
hemolysin (Bayley, 1994) using two adherent cell lines, A10 and CPAE. The earlier studies had 
been done with cells in suspension (Eroglu et al., 2000). We also evaluated sucrose, another 
disaccharide sugar that is commonly found in nature, for its potential usefulness as a 
cryoprotectant. Using the protocol of Eroglu et al as a starting point, a protocol was established 
for adherent cells. Several parameters were evaluated and included the H5 concentration, time 
of poration, concentration of trehalose loaded, and time for loading trehalose. Conditions that 
worked best with adherent cells included 20 minutes for poration followed by 60 minutes for 
trehalose loading. The highest concentration of trehalose that caused the least drop in cell 
viability was 0.2M. The optimum H5 concentration varied according to cell type. The A10 
smooth muscle cells were porated with 12.5 µg/mL of H5 while the endothelial CPAE cells 
were porated with 50 µg/mL. In contrast, the fibroblasts and keratinocytes in the literature 
were porated with 25 µg/mL (Eroglu et al., 2000). Other changes to the protocol were made 
that benefited viability for adherent cells specifically and included addition of trehalose prior 
to the addition of H5, the base solution used for poration, and the amount of EDTA (1 mM 
versus 10 mM) for the removal of Zn+ prior to poration. After cryopreservation, however, poor 
viability was obtained with both cell types. A10 cells demonstrated a viability of 5.57±0.17%. 
The endothelial cells demonstrated similar viabilities. These values were not as good as those 
observed when suspended cells were cryopreserved with sugars in the literature. However, it 
is our experience that adherent cells are generally more difficult to cryopreserve regardless of 
the cryoprotectant used.  
3.2 Trehalose exposure without poration 
When we started adding the trehalose to cells in the H5 experiments, control cells were 
exposed to trehalose by addition to the culture medium prior to cryopreservation. An 
unanticipated observation of cell survival was made with slow rate cryopreserved CPAE 
cells prompting further investigation. The cells exposed to trehalose overnight were 
observed to develop vacuoles (Fig 1) suggesting a possible pinocytotic uptake mechanism.  
  
Fig. 1. CPAE cells after exposure to trehalose. Left: no sugar, Right: 0.1M trehalose. 40X 
magnification 
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After these observations were made, further experiments were designed to examine cell 
viability after extended trehalose exposure. CPAE cells were exposed to 0.2M trehalose in 
Dulbecco’s Modified Eagle’s Medium (DMEM) buffered with 25 mM Hepes for 0-72 hours 
at 37oC. After exposure the cells were left in 0.2M trehalose and cryopreserved at ~-
1.0oC/min (Fig. 2). CPAE cell viability was observed immediately after thawing. An 
exposure time of 24 hours provided the best overall cell survival. Extracellular exposure 
alone during cryopreservation failed to produce any cell survival. In contrast, A10 smooth 
muscle cells generally did not survive cryopreservation after trehalose exposure as well as 
the CPAE endothelial cells.  Examination of optimal concentrations of trehalose during 
incubation and during cryopreservation showed that a concentration of 0.1-0.2M trehalose 
for incubation produced the best viability with a similar concentration being required 
during the freezing process.  
 
Fig. 2. Impact of cell culture time with trehalose on cryopreservation. CPAE cells were 
cultured with 0.2M trehalose for up to 72 hours followed by cryopreservation with 0.2M 
trehalose. Percent viability was calculated based on the pre-cryopreservation controls. 
(p<0.05)  
Several other parameters were also examined to further improve cell viability. Other studies 
have shown that not only the concentration and choice of cryoprotectant but also the vehicle 
solution for the cryoprotectant can have a significant impact on cell viability after 
cryopreservation (Campbell & Brockbank, 2007; Mathew et al., 2004; Sosef et al., 2005). 
Initial experiments were performed using DMEM, however, it was observed that CPAE 
cells, which are grown in EMEM medium, actually preferred exposure to trehalose in 
EMEM medium. Further experiments examined the buffers used to maintain the pH of the 
system. Four cell lines were evaluated. CPAE cells demonstrated decreased viability when 
the zwitteronic buffer, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) was 
used while the other 3 cell lines did not show decreased viability. Rather a combination of 
HEPES and sodium bicarbonate was preferred by the CPAE cells. This unusual choice of 
buffer prompted examination of solution pH during incubation, a pH of 7.4 was optimal for 
all the 4 cell lines tested. Once loaded with sugar, the cells could either be left in the 
extracellular sugar at another concentration or an alternative cryoprotectant for 
preservation. 
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These studies were then extended to include other sugars, sucrose, raffinose, and stachyose 
(Fig. 3). The potential cryoprotective benefits of these sugars were evaluated and it was 
found that stachyose was as good as trehalose using an identical protocol, sucrose was not 
quite as good and raffinose had very little benefit. All cell lines showed evidence of some 
cell survival days after cryopreservation and thawing. The second smooth muscle cell line, 
A7R5, demonstrated low levels of viability with stachyose. Both endothelial cell lines, CPAE 
and BCE, showed good viability after exposure and freezing with sucrose. Overall, the 
CPAE cell line had the best viability in these experiments. Use of an optimized protocol with 
trehalose produced excellent post cryopreservation results with 10-14mM intracellular 
trehalose (Campbell, 2011). Conditions included 24 hours of cell culture with 0.2M trehalose 
followed by cryopreservation with 0.2-0.4M trehalose in sodium bicarbonate buffered 
EMEM at pH 7.4 resulting in ~75% post-preservation cell viability (Campbell et al., 
2011).These experiments confirmed that this technique is more effective for endothelial cells 
than smooth muscle cells and demonstrated that stachyose is effective for cryopreservation.  
 
Fig. 3. Cell viability for A10 (A), CPAE (B), A7R5 (C) and BCE (D) cells after exposure and 
freezing in the presence of sugars. 
3.3 ATP poration 
In addition to the H5 mutant ǂ-hemolysin poration strategy, we sought other poration 
techniques that could be used to permeate mammalian cells with disaccharides. Cells 
expressing the P2X7 purinergic cell surface receptor, also known as the P2z receptor, may be 
permeabilized by the formation of a channel/pore that allows passage of molecules into and 
out of the cell when the active form of ATP (ATP4-) binds to the receptor. Our initial studies 
focused on determination of whether or not the P2X7 was expressed on smooth muscle and 
endothelial cells. Experiments using the ELICA assay demonstrated the presence of the P2X7 
receptor on both endothelial and smooth muscle cell lines to varying degrees (Fig 4). The 
smooth muscle cell lines demonstrated the greatest density of the receptor.  
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Fig. 4. Detection of the P2X7 receptor by ELICA. Cells were probed for the presence of the 
P2X7 receptor using antiserum specific for the receptor at a dilution of 1:25. The graph 
represents the average absorbance (±SEM) for 10 replicates. 
ATP-permeabilized cells retained better viability than untreated cells both immediately after 
thawing and five days later (Fig 5). Immediate metabolic activity in A7R5 and CPAE cells 
demonstrated dependence upon increasing ATP concentrations, while for A10 and BCE cells 
immediate metabolic activity was increased at all ATP concentrations with only slight 
improvement at the higher concentrations tested. However, survival at five days 
demonstrated that intermediate concentrations of ATP (0.5-2.5mM) were best.  Further 
cryopreservation studies were performed to optimize cell survival resulting in at least 25% 
cell survival for both endothelial cell lines but only low levels of survival for the smooth 
muscle cells.   
 
Fig. 5. Cell viability after poration and freezing with increasing concentrations of ATP. Cells 
were loaded with 0.2M trehalose using the P2X7 receptor and the indicated concentrations of 
ATP. After poration and cryopreservation, cell viability was evaluated by alamarBlue. (A) 
A10, (B) A7R5, (C) CPAE, (D) BCE.  
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4. Discussion 
As cryopreservation has been applied to cells and tissues for clinical use, concerns about 
toxicity relating to the various cryoprotectants being used, particularly DMSO, have 
developed. Because of this, there has been renewed interest in finding less toxic 
cryoprotectants. The cryoprotective capabilities of some sugars, disaccharide sugars in 
particular, has been known for years and early work with them demonstrated their ability to 
protect proteins and membrane vesicles during freezing (Crowe et al., 1990; Rudolph & 
Crowe, 1985). Coupled with these early studies are observations made in nature regarding 
organisms that can survive extremes in temperature and desiccation due to their ability to 
accumulate large amounts of disaccharide sugars, specifically trehalose and sucrose, until 
more favorable conditions are available. The protective effects of trehalose and sucrose have 
been determined and may be classified under two general mechanisms: (1) “the water 
replacement hypothesis” or stabilization of biological membranes and proteins by direct 
interaction of sugars with polar residues through hydrogen bonding, and (2) stable glass 
formation (vitrification) by sugars in the dry state (Crowe et al., 1987, 1988, 1998, 2001; Slade 
& Levine, 1991).  
Two primary stresses that destabilize membranes have been defined, fusion and lipid phase 
transition. Studies have shown that when the water that hydrates the phospholipid 
molecules of the membrane is removed, packing of the head groups increases. The result is 
an increase in van der Waals interactions and a dramatic increase in the phase transition 
temperature (Tm) (Crowe et al., 1987, 1988, 1990, 1991). At the phase transition the 
phospholipid bilayer shifts from a gel phase to a liquid crystalline phase, the state normally 
observed in fully hydrated cells. For example, the Tm of a cell membrane might be -10oC 
when fully hydrated but when water is removed the Tm increases to over 100oC. Thus, the 
membrane is in the gel phase at room temperature. As the membrane shifts between the gel 
phase and the liquid crystalline phase it becomes transiently leaky allowing its intracellular 
contents to leak out. Therefore it would be advantageous to avoid the lipid phase transition 
as this can compromise the health of a rehydrated cell. Addition of disaccharide sugars, in 
particular trehalose, depresses Tm allowing the membrane to remain in the liquid crystalline 
state even when dried, so that upon rehydration no phase transition takes place and no 
transient leaking. During cryopreservation water is not necessarily lost, but it undergoes a 
phase change forming ice as the temperature drops and depending upon the rate of cooling, 
the cells become more or less dehydrated rendering the cells vulnerable to damage by 
mechanisms similar to those proposed for desiccated cells.  
The stabilizing effect of these sugars has been shown in a number of model systems 
including liposomes, membranes, viral particles, and proteins. The mechanism by which 
disaccharide sugars are able to decrease the Tm for a given bilayer has been elucidated. 
Interactions take place between the sugars and the –OH groups of the phosphate in the 
phospholipid membrane preventing interaction or fusion of the head groups as the 
structural water is removed (Crowe et al., 1986, 1988, 1989a, 1989b). Although not as well 
understood, a similar mechanism of action stabilizes proteins during drying (Carpenter et 
al., 1986, 1987a, 1987b, 1989). Despite their protective qualities, the use of these sugars in 
mammalian cells has been somewhat limited mainly because mammalian cell membranes 
are impermeable to disaccharides or larger sugars and there is strong evidence that sugars 
need to be present on both sides of the cell membrane in order to be effective (Crowe et al., 
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2001; Eroglu et al., 2000; Beattie et al., 1997). This is why, in addition to loading sugars, we 
added sugars to the cryopreservation solution just before initiating cooling. 
In addition to trehalose and sucrose, we were interested in other sugars that could be used 
as cryoprotectants avoiding monosacharides that would likely be degraded in the cell. 
Larger more complex sugars such as disaccharides or larger would be less likely to be 
degraded and utilized inside cells and might therefore be more stable as cryoprotectants. 
The comparative structures of the sugars we considered for preservation of mammalian cells 
are illustrated in Figure 6. Three other sugars were evaluated besides trehalose and included 
sucrose, raffinose and stachyose. Sucrose and trehalose are both non-reducing sugars, so 
they do not react with amino acids or proteins and should be relatively stable under low pH 
conditions and at temperature extremes. Raffinose is a trisaccharide and stachyose is a 
tetrasaccharide. 
 
Sucrose (mw: 342.30) 
 
Trehalose (mw: 342.30) 
 
 
Stachyose (mw: 684.59) 
 
Raffinose (mw: 504.44) 
Fig. 6. Sugar structure 
Before going further, it is important to point out that the cells we have employed were 
cryopreserved and thawed while adherent in 96-well plates using cooling and warming 
conditions defined and reported at the turn of the century (Campbell et al., 2003; Taylor et 
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al., 2001). We have since used these conditions to cryopreserve several adherent cell types 
(Campbell et al., 2007, 2010, 2011). Our rationale for using this adherent model was two-
fold. First, due to our interest in regenerative medicine we thought that adherent cells more 
closely mimicked cells in tissue engineered devices. Second, we thought there might be a 
market for cells cryopreserved on plates for research and cytotoxicity testing, CryoPlate™.  
More recently another group has been using adherent cells for investigation of preservation 
by vitrification and drying and have reported on cryopreservation of adherent pluripotent 
stem cells (Katkov et al., 2006;  Katkov et al., 2011;). Katkov et al. presented results for 
preservation of human embryonic stem cells in 4-well plates and pointed out several 
advantages of cryopreservation in adherent mode. These included elimination of possible 
bias due to selective pressure within a pluripotent stem cell line after cryopreservation and 
distribution of multiwell plates for immediate use for embryotoxicity and drug screening in 
pluripotent stem cell-based toxicology in vitro kits (Katkov et al., 2011). 
There are several methods in the literature that could be employed for intracellular delivery 
of these sugars including those already discussed (Campbell et al., 2011; Table 2). Many 
drugs, therapeutic proteins and small molecules have unfavorable pharmacokinetic 
properties and do not readily cross cell membranes or other natural physiological barriers 
within the body. This has resulted in the search for and discovery of alternative methods to 
transport materials, like sugars, across mammalian cell membranes.  
Some of these strategies have been presented in depth in the results sections. The first 
involved the use of the Staphylococcus aureus toxin, ǂ-hemolysin. This toxin is produced as a 
monomer by the bacteria. It then oligomerizes to form pores on mammalian cell 
membranes. Hagan Bayley and his group modified the wild type ǂ-hemolysin protein by 
replacing 4 native residues with histidines, termed H5. In addition to pore formation on cell 
membranes, the H5 mutant also enabled it to be opened and closed at will. When inserted 
into the membrane, it is open and molecules up to 3000 daltons are able to pass through. 
Then the pores are closed in the presence of Zn+. To reopen the pore, addition of a chelating 
agent such as EDTA will remove the Zn+ and the pore is ready to be used again (Bayley, 
1994; Walker et al., 1995). Early studies showed that H5 could create pores in mammalian 
cell membranes and that they could be used for efficient intracellular loading of trehalose 
(Eroglu et al, 2000; Acker et al., 2003). Our experiments with H5 worked well initially using 
adherent cells. The results demonstrated good poration and loading of trehalose into cells. 
However, after adherent cells were cryopreserved, their viability was not very good (<6%). 
At this point in our studies, several issues arose that prevented further studies using H5. 
First, the H5 pore was derived from the bacterial toxin ǂ-hemolysin so there were concerns 
raised whether regulatory approval could be obtained if it was ever to be used clinically 
with human cells and tissues. There were some indications during these studies that the 
pores were shed from the membrane over time. However, H5 was still detectable in 
picogram quantities after 7 days in culture. Finally, as new batches of H5 were delivered the 
activity varied greatly and more H5 was required to achieve the same level of poration 
compared with earlier batches. Ultimately the batch variation was attributed to a protein 
stability issue. When these issues were not resolved other strategies for introducing 
trehalose into cells were explored. 
An unexpected outcome of our H5 experiments was the development of a new, simple 
strategy for introduction of trehalose into cells which involved incubating cells in sugar for 
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extended periods of time at physiological temperature (Brockbank, 2007). One possible 
mechanism to explain this observation was that the trehalose is substituting for water 
molecules in the cell membranes keeping the membrane stable and preventing it from going 
through a phase transition (Crowe et al., 1988, 1989). A second mechanism is most likely an 
active uptake mechanism involving endocytosis similar to that proposed for loading of 
trehalose by Oliver et al (Oliver et al., 2004). Her results suggested that human MSCs are 
capable of loading trehalose from the extracellular space by a clathrin-dependent fluid-
phase endocytotic mechanism that is microtubule-dependent but actin-independent (Oliver 
et al., 2004). Further research is required to elucidate the mechanism by which culture in the 
presence of trehalose facilitates cell cryopreservation and determine the degree of cell 
viability retention under different storage conditions.  
The last method presented was poration using the P2z receptor and ATP. This was a 
somewhat unique strategy in that it took advantage of the cell’s own machinery. It was 
shown that cells expressing the P2X7 purinergic cell surface receptor, also known as the P2z 
receptor, could be permeabilized when the receptor binds to ATP4-. The interaction with 
ATP resulted in the formation of a non-selective pore that allows molecules up to ~900 
Daltons to pass through (Nihei et al., 2000). The P2X7 receptor selectively binds to only ATP4- 
whose presence in solution is dependent on temperature, pH, and the concentration of 
divalent cations such as Mg2+. Closure of the pore after activation by ATP is achieved by 
simply removing ATP from the system or adding exogenous Mg2+ that has a high affinity 
for the active form of ATP, ATP4-. The P2z receptor is found on a number of cell types 
including cells of hematopoietic origin (Nihei et al, 2000). There were several factors that 
likely affected the cell viability and survival of cells after ATP poration. First, is the density 
of the receptor on the cells which directly affects the amount of trehalose that can be loaded 
into the cells and how long it takes. Another factor is that poration with ATP tends to 
promote the detachment of adherent cells from their substrate. Part of the protocol requires 
a recovery period of 1 hour at 37oC to allow cells that may have been perturbed by the 
poration process the chance to settle back onto their substrate.  Finally, cell loss is at least in 
part due to apoptosis. There is evidence in the literature that poration with ATP induces 
apoptosis in some cell types (Murgia et al., 1992). 
In marked contrast the human stem cell line, TF-1, demonstrated excellent post 
cryopreservation survival (Buchanan et al., 2004; 2005). We have exposed TF-1 cells to ATP 
with trehalose for 1 hour followed by a 10-fold dilution of the ATP and inactivation of the 
active form of ATP (ATP 4-) by the addition of 1 mM MgCl2 followed by a 1-hour recovery 
period at 37oC (Brockbank et al., 2011). When the cells were compared to cells cryopreserved 
with 10% DMSO, the DMSO group demonstrated greater initial viability close to 100% that 
steadily declined over days in culture post thaw. However by day 4 of culture post-
cryopreservation cells cryopreserved in disaccharides were similar to the viability of cells 
cryopreserved in DMSO. Similarly colony forming assays with TF-1 cells demonstrated 
similar outcomes compared with DMSO. Furthermore, the use of disaccharides, trehalose 
and sucrose, appeared to result in similar results at both slow (1°C/min) and rapid 
(100°C/min) cooling rates. Buchanan et al (Buchanan et al., 2010) have extended these 
studies obtaining excellent TF-1 cell line and cord blood-derived multipotential 
hematopoietic progenitor cell survival after freeze drying and storage at room temperature 
for 4 weeks! It is studies such as Buchanan’s that keep us optimistic that disaccharide 
introduction/preservation strategies can be developed for preservation of other mammalian 
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cell types. Further development work is required with the cell culture and P2x7 methods 
with the promise of preservation by freezing and freeze-drying.  
 
Existing 
Techniques 
Description Pitfalls References 
H5 
Derived from ǂ-hemolysin, 
which normally forms a 
constitutively opened pore 
in the membrane. 
Engineered to close in the 
presence of Zn+ or serum. 
Derived from a 
bacterial toxin. 
Batch to batch 
variation and 
instability. 
Acker et al. 2003 
Bayley, 1994 
Eroglu et al. 
2000 
ATP 
The naturally occurring 
p2x7 receptor forms a non-
specific pore upon binding 
of ATP4- able to allow 
molecules <900 daltons to 
pass through. 
P2x7 receptor found 
on some but not all 
cell types. 
Buchanan et al. 
2005 
Culture 
methods 
1) Prolonged incubation of 
cells in the presence of 
disaccharide sugars at 37oC. 
2) Fluid phase endocytosis: 
disaccharide sugars are 
taken up by cells via a 
clathrin dependent 
endocytotic mechanism. 
Works better with 
some cells but not 
others. 
Brockbank et al. 
2007 
Oliver et al. 
2004 
Temperature 
manipulation 
A shift in temperature can 
cause a lipid phase 
transition which 
temporarily changes the 
membrane permeability 
and allows molecules to 
pass through. 
Has been 
demonstrated with 
pancreatic islets and 
kidney cells. 
Requires 
optimization by cell 
type. 
Beattie et al. 
1997 
Mondal 2009 
Table 2. Strategies for Loading Disaccharide Sugars  
There are still other methods in the literature that could lead to intracellular delivery of 
disaccharides in addition to those already discussed (Campbell et al., 2011; Table 2). One 
method takes advantage of the lipid phase transition described above when the cell 
membrane is exposed to changes in temperature. As the membrane changes from the liquid 
crystalline phase to the gel phase it becomes leaky providing an opportunity to introduce 
molecules into the cell that would not normally cross like trehalose. Beattie used this 
method to cryopreserve pancreatic islets by introducing DMSO and trehalose into the islets 
during the thermotropic phase transition between 5 and 9oC. The islets were then 
cryopreserved in combination with DMSO and the viability of the islets after thawing was 
greater than when DMSO alone was used, 94% versus 58% (Beattie et al., 1997). In a related 
study, Mondal et al, cryopreserved kidney cells (MDBK) using 264 mM trehalose. The cells 
were suspended in trehalose with 20% fetal bovine serum in culture medium then incubated 
at 40oC for 1 hour before slow rate cooling for storage at -80oC. Viability was measured 
using Trypan Blue exclusion at 74% upon thawing (Mondal, 2009).  
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In another variation for loading molecules into cells, a number of proteins have been 
discovered that possess the ability to cross the cell membrane. These protein transduction 
domains (PTDs) generally correspond to portions of native proteins. Examples of PTDs 
include the Tat protein from the human immunodeficiency virus type I, the envelope 
glycoprotein Erns from the pestivirus and the DNA binding domains of leucine zipper 
proteins such as c-fos, c-jun and yeast transcription factor GCN4 (Futaki et al., 2001, 2004; 
Langedijk, 2002; Langedijk et al., 2004; Lindgren et al., 2000; Richard et al., 2003; Vives et al., 
1997). These PTDs are short cationic peptides that cross the cell membrane in a 
concentration-dependent manner that is independent of specific receptors or other 
transporters. The exact mechanism of translocation has not been defined. Enrichment of 
basic amino acids, particularly arginine and in some instances lysine, have been shown to be 
important for the translocation activity (Futaki et al., 2001, 2004; Vives et al., 1997). Some 
studies have suggested that endocytosis is involved (Lundberg & Johansson, 2002; Richard 
et al., 2003), however, the current theory includes interaction with glycosaminoglycans and 
uptake by a non-endocytotic mechanism that may involve the charged heads of the 
phospholipid groups within the cell membrane. (Langedijk, 2002; Langedijk et al., 2004; Mai 
et al., 2002).  
While most of these peptides need to be cross linked to the molecule of interest, there are 
peptides that can move proteins and other peptides across the membrane without the 
requirement for cross-linking. Examples include Pep-1, a 21-residue peptide which contains 
three domains; a tryptophan rich region (5 residues) for targeting the membrane and 
forming hydrophobic interactions; a lysine rich domain to improve intracellular delivery 
whose design was taken from other nuclear localization sequences from other proteins like 
the simian virus 40 large T antigen, and, a spacer region with proline that provides 
flexibility and maintenance of the other two regions. When mixed with other peptides or 
proteins, Pep-1 rapidly associates and forms a complex with the protein of interest by 
noncovalent hydrophobic interactions to form a stable complex. Once in the cytoplasm the 
peptide dissociates from the protein that has been carried across the membrane causing little 
if any interference regarding the protein’s final destination or function. The process occurs 
by an endocytosis independent mechanism (Morris et al., 1999, 2001). We anticipate that 
such peptides may eventually lead to methods for introduction of disaccharides into 
mammalian cells (Campbell et al., 2011). 
Another alternative method is electroporation, also called electropermeabilization, which 
involves the application of an electric pulse that briefly permeabilizes the cell membrane. 
Since its introduction in the 1980’s it has been primarily used to transfect mammalian cells 
and bacteria with genetic material. Initially electroporation tended to kill most cells. 
However, further work and development of the electroporation process, such as alternate 
electrical pulses like the square wave pulse, have refined the process so that better 
permeabilization and cell viability can be achieved (Gehl, 2003; Hapala, 1997; Heiser, 2000). 
The formation of pores, their size and the recovery of the membrane are important factors 
that influence the success of an electroporation protocol (Gehl, 2003; Hapala, 1997; Heiser, 
2000). Most importantly, electroporation is applicable to all cell types. 
It was hypothesized that trehalose provided protection during electropermeabilization in a 
manner similar to chelating agents such as EDTA or lipids like cholesterol (Katkov, 2002; 
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Mussauer et al., 2001). Effective electroporation protocols are a balance between how much 
material can be loaded into the cells and cell survival after membrane permeabilization. So, 
while it cannot be predicted how well certain cell types will respond to electroporation, 
there is ample evidence that electroporation can be used with a reasonably certainty of 
success. A short culture period may be all that is required to permit restabilization of 
membranes post-electroporation. Additionally, like trehalose which interacts with 
membranes under stressful conditions such as drying, other compounds, such as cholesterol 
and unsaturated fatty acids, can also interact with membranes and may facilitate resealing 
of the membranes increasing overall cell survival (Katkov, 2002). Efficient resealing of cell 
membranes after permeabilization is thought to be essential for promoting cell recovery 
(Gehl et al., 1999) and compounds such as Poloxamer 188 facilitate membrane resealing (Lee 
et al., 1992).  
5. Conclusion 
In conclusion, there are multiple potential ways to introduce trehalose into mammalian cells 
and in some cases excellent cell preservation can be achieved. However, it is clear that 
methods for each cell type will need to be diligently developed and many years of work 
remain before we can replace DMSO as the lead cryoprotectant. In the mean time, we must 
not forget that there are other relatively low molecular weight sugars available.  Preliminary 
evidence suggests that with further work sucrose and stachyose may, in some cases, be 
equally effective for cell preservation. 
6. Acknowledgements 
We would like to thank Elizabeth Greene for her assistance in the preparation of this 
manuscript. This work was supported by a cooperative agreement (No. 70NANB1H3008) 
between the U.S. Department of Commerce, National Institute of Standards and 
Technology— Advanced Technology Program, and Organ Recovery Systems, Inc 
7. References 
Acker, J.P., Lu, X.M., Young, V., Cheley, S., Bayley, H., Fowler, A. & Toner M. (2003). 
Measurement of trehalose loading of mammalian cells porated with a metal-
actuated switchable pore. Biotechnology and Bioengineering, Vol.82, No.5, (June 2003), 
pp. 525-32, PMID: 12652476. 
Barnett, R. (1978). The effects of dimethyl sulfoxide and glycerol on Na+. K+-ATPase and 
membrane structure. Cryobiology, Vol.15, (April 1978), p. 227, PMID: 149651.. 
Bayley, H. (1994). Triggers and Switches in a Self-Assembling Pore-Forming Protein. Journal 
of Cellular Biochemistry, Vol.56, (October 1994), pp. 177-82, PMID: 7829577. 
Beattie, G.M., Crowe, J.H., Lopez A.D., Cirulle, V., Ricordi, C. & Hayek, A. (1997). Trehalose: 
A cryoprotectant that enhances recovery and preserves function of human 
pancreatic islets after long-term storage, Diabetes, Vol.46, (March 1997), pp. 519-23, 
PMID: 9032112. 
www.intechopen.com
 Cryopreservation of Adherent Smooth Muscle and Endothelial Cells with Disaccharides 31 
Brockbank, K.G.M., Campbell, L.H., Ratcliff, Kelly M. & Sarver, K.A. (2007, 2011). Method 
for treatment of cellular materials with sugars prior to preservation. U.S. Patents 
#7,270,946, #8,017,311.  
Brockbank, K.G.M., Campbell, L.H., Greene, E.D., Brockbank, M.C.G. & Duman, J.G. (2011). 
Lessons Learned from Nature for Preservation of Mammalian Cells, Tissues and 
Organs, In Vitro Cellular & Developmental Biology–Animal, Vol.47, No.3, (March 
2011), pp. 210-217, PMID: 21191664.  
Buchanan, S.S., Gross, S.A., Acker, J.P., Toner, M., Carpenter, J.F., & Pyatt, D.W. (2004). 
Cryopreservation of Stem Cells Using Trehalose: Evaluation of the Method Using a 
Human Hematopoietic Cell Line, Stem Cells and Development, Vol.13, (June 2004), 
pp. 295–305, PMID: 15186725.  
Buchanan, S.S.; Menze, M.A.; Hand, S.C.; Pyatt, D.W.& Carpenter, J.F. (2005). 
Cryopreservation of Human Hematopoietic Stem and Progenitor Cells Loaded 
with Trehalose: Transient Permeabilization via the ATP-Dependent P2Z Receptor 
Channel, Cell Preservation Technology, Vol. 3, No.4, (2005), pp. 212–22. 
Buchanan, S.S., Pyatt, D.W. & Carpenter J.F. (2010). Preservation of Differentiation and 
Clonogenic Potential of Human Hematopoietic Stem and Progenitor Cells during 
Lyophilization and Ambient Storage, PLoS ONE, Vol.5, No.9, (September 2010), pp. 
e12518, PMID: 20824143. 
Campbell, L.H., Taylor, M.J. & Brockbank, K.G.M. (2003) Two stage method for thawing 
cryopreserved cells, U.S. Patent #6,596,531. 
Campbell, L.H., & Brockbank, K.G.M. (2007). Serum free solutions for the cryopreservation 
of cells, In Vitro Cellular & Developmental Biology–Animal, Vol.43, No.8-9, (September 
2007), pp. 269-275, PMID: 17879124. 
Campbell, L.H., Brockbank, K.G.M. (2011). Comparison of Electroporation and Chariot™ for 
Delivery of ǃ-galactosidase into Mammalian Cells: Strategies to Use Trehalose in 
Cell Preservation, In Vitro Cellular & Developmental Biology–Animal, Vol.47, No.3, 
(March 2011), pp.195-199, PMID: 21184200. 
Campbell, L.H., Sarver, K.A., Hylton, K.R., Leman, B.B., & Brockbank, K.G.M. (2011). 
Culturing with trehalose produces viable endothelial cells after cryopreservation, 
Cryobiology, Submitted, 2011. 
Carpenter, J.F., Hand, S.C., Crowe, L.M., & Crowe, J.H. (1986). Cryoprotection of 
Phosphofructokinase with Organic Solutes: Characterization of Enhanced 
Protection in the Presence of Divalent Cations, Archives of Biochemistry and 
Biophysics, Vol.250, No.2, (November 1986), pp. 505-1, PMID: 2946263. 
Carpenter, J.F., Crowe, L.M .& Crowe JH. (1987a). Stabilization of Phosphofructokinase with 
Sugars During Freeze-Drying: Characterization of Enhanced Protection in the 
Presence of Divalent Cations, Biochimica et Biophysica Acta, Vol.923, No.1, (January 
1987), pp. 109-15, PMID: 2948571. 
Carpenter, J.F., Martin, B., Crowe, L.M. & Crowe, J.H. (1987b). Stabilization of 
Phosphofructokinase During Air-Drying with Sugars and Sugar/Transition 
Metal Mixtures, Cryobiology, Vol.24, No.5, (October 1987), pp. 455-64, PMID: 
2958239. 
www.intechopen.com
 Current Frontiers in Cryopreservation 32
Carpenter, J.F. & Crowe, J.H. (1989). An Infrared Spectroscopic Study of the Interactions of 
Carbohydrates with Dried Proteins, Biochemistry, Vol.28, No.9, (May 1989), pp. 
3916-22, PMID: 2526652. 
Caselli, D., Tintori, V., Messeri, A., Frenos, S., Bambi, F. & Arico, M. (2009). Respiratory 
depression and somnolence in children receiving dimethyl sulfoxide and morphine 
during hematopoietic stem cell transplantation. Haematologica, Vol.94. No. 1, 
(January 2009), pp. 152–153, PMID: 19001279. 
Crowe, L.M., Womersley, C., Crowe, J.H., Reid, D., Appel, L. & Rudolph, A. (1986). 
Prevention of Fusion and Leakage in Freeze-Dried Liposomes by Carbohydrates”. 
Biochimica et Biophysica Acta, Vol.861, (1986), pp. 131-40. 
Crowe, J.H., Crowe, L.M., Carpenter, J.F. & Aurell Wistrom, C. (1987). Stabilization of Dry 
Phospholipid Bilayers and Proteins by Sugars, The Biochemical Journal, Vol.242, 
No.1, (February 1987), pp. 1-10, PMID: 2954537. 
Crowe, J.H., Crowe, L.M., Carpenter, J.F., Rudolph, A.S. & Aurell Wistrom, C., Spargo, B.J. 
& Anchordoquy, T.J. (1988). Interactions of Sugars with Membranes, Biochimica et 
Biophysica Acta, Vol.947, No.2, (June 1988), pp. 367-84, PMID: 3285894. 
Crowe, J.H., Crowe, L.M. & Hoekstra, F.A. (1989a). Phase Transitions and Permeability 
Changes in Dry Membranes During Rehydration, Journal of Bioenergetics & 
Biomembranes, Vol.21, No.1, (February 1989), pp. 77-91. 
Crowe, J.H., McKersie, B.B. & Crowe, L.M. (1989b). Effects of Free Fatty Acids and 
Transition. Temperature on the Stability of Dry Liposomes, Biochimica et Biophysica 
Acta, Vol.979, No.1, (February 1989), pp. 7-10, PMID: 2917168. 
Crowe, J.H., Carpenter, J.F., Crowe, L.M. & Anchordoguy, T.J. (1990). Are Freezing and 
Dehydration Similar Stress Vectors? A Comparison of Modes of Interaction of 
Stabilizing Solutes with Biomolecules, Cryobiology, Vol.27, No.3, (June 1990), pp. 
219-31.  
Crowe, J.H. & Crowe, L.M. (1991). Preservation of Liposomes by Freeze Drying, In: Liposome 
Technology, G. Gregoriadis, CRC Press, ISBN 0849340764, Boca Raton, FL. 
Crowe, J.H., Carpenter, J.F. & Crowe, L.M. “( 1998). The role of Vitrification in 
Anhydrobiosis, Annual Review of Physiology, Vol.60, (1998), pp. 73-103, PMID: 
9558455. 
Crowe, J.H., Crowe, L.M., Oliver, A.E., Tsvetkova, N., Wolkers, W. & Tablin, F. (2001). The 
Trehalose Myth Revisited: Introduction to a Symposium on Stabilization of Cells in 
the Dry State, Cryobiology, Vol.43, No.2, (September 2001), pp. 89-105, PMID: 
11846464. 
Eroglu, A., Russo, M.J., Bieganski, R., Fowler, A., Cheley, S., Bayley, H. & Toner, M. 
(2000). Intracellular trehalose improves the survival of cryopreserved 
mammalian cells, Nature Biotechnology, Vol.18, No.2, (February 2001), pp. 163-67, 
PMID: 10657121. 
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda. K., Sugiura, Y. (2001). 
Arginine-rich Peptides: An Abundant Source of Membrane-Permeable Peptides 
having Potential as Carriers for Intracellular Protein Deliver, Journal of Biological 
Chemistry, Vol. 276, No.8, (February 2000), pp. 5836-40, PMID: 11084031. 
www.intechopen.com
 Cryopreservation of Adherent Smooth Muscle and Endothelial Cells with Disaccharides 33 
Futaki, S., Goto, S., Suzuki, T., Nakase, I. & Sugiura, Y. (2004). Structural Variety of 
Membrane Permeable Peptides, Current Protein & Peptide Science, Vol.4, No.2, (April 
2004), pp. 87-96, PMID: 12678848. 
Gehl, J., Sorensen, T.H. & Nielsen, K. (1999). In Vivo Electroporation of Skeletal Muscle: 
Threshold, Efficacy and Relation to Electric Field Distribution, Biochimica et 
Biophysica Acta, Vol.1428, No.2, (August 1999), pp. 233-40, PMID: 10434041 
Gehl, L. (2003). Electroporation: theory and methods, perspectives for drug delivery, gene 
therapy and research, Acta Physiologica Scandinavica, Vol.177, No.4, (April 2003), pp. 
437-47, PMID: 12648161 
Hapala, I. (1997). Breaking the Barrier: Methods of reversible permeabilization of cellular 
membranes, Critical Reviews in Biotechnology, Vol.17, No.2, (1997), pp. 105-22, PMID: 
9192473. 
Heiser, W.C. (2000). Optimizing electroporation conditions for the transformation of 
mammalian cells, Methods in Molecular Biology, Vol.130, (2000), pp. 117-34, 2000. 
PMID: 10589426 
Junior, A.M., Arrais, C.A., Saboya, R., Velasques, R.D., Junqueira, P.L. & Dulley, F.L. (2008). 
Neurotoxicity associated with dimethyl sulfoxide-preserved hematopoietic 
progenitor cell infusion. Bone Marrow Transplantation, Vol.41, No. 1, (January 2008), 
pp. 95–6, PMID: 17934528. 
Katkov, I. (2002). Electroporation of cells in applications to cryobiology: summary of 20-year 
experience, Problems of Cryobiology, Vol.2, (2002), pp. 3-8. 
Katkov, I., Isachenko, V., Isachenko, E., Kim, M., Lulat, A., Mackay, A. & Levine, F. (2006). 
Low- and high-temperature vitrification as a new approach to biostabilization of 
reproductive and progenitor cells, International Journal of Refrigeration, Vol.29, 
(February 2006), pp. 346-357. 
Katkov, I., Kan, N., Cimadamore, F., Nelson, B., Snyder, E., Terskikh, A. (2011). DMSO-Free 
programmed cryopreservation of fully dissociated and adherent human induced 
pluripotent stem cells, Stem Cells International, Vol.2011, (June 2011), pp.1-8, PMID: 
21716669. 
Katsuda, S., Okada, Y., Nakanishi, I. & Tanaka, J. (1984). The influence of dimethyl sulfoxide 
on cell growth and ultrastructural features of cultured smooth muscle cells, Journal 
Electron Microscopy, Vol.33, No. 3, (July 1984), pp. 239-241, PMID: 6533232. 
Katsuda, S., Okada, Y. & Nakanishi, I. (1987). Dimethyl sulfoxide induces microtubule 
formation in cultured arterial smooth muscle cells. Cell Biology International Reports, 
Vol.11, (February 1987), pp. 103-110, PMID: 3549003. 
Langedijk, J.P.M. (2002), Translocation Activity of C-terminal Domain of Pestivirus Erns and 
Ribotoxin L3 Loop, Journal of Biological Chemistry, Vol.277, No.7, (February 2002), 
pp. 5308-14, PMID: 11673454. 
Langedijk, J.P.M., Olijhoek, T., Schut, D., Autar, R. & Meloen, R.H. (2004). New Transport 
Peptides Broaden the Horizon of Applications for Peptidic Pharmaceuticals, 
Molecular Diversity, Vol. 8, No.2, (2004), pp. 101-11, PMID: 15209161 
Lee, R.C., River, L.P., Pan, F.S. & Ji, L. (1992). Surfactant-Induced Sealing of 
Electropermeabilized Skeletal Muscle Membranes In Vivo, Proceedings of the 
www.intechopen.com
 Current Frontiers in Cryopreservation 34
National Academy of Sciences USA, Vol.89, No.10, (May 1992), pp. 4524-28, PMID: 
1584787 
Lindgren, M., Hällbrink, M., Prochiantz, A., Langel, Ü. (2000). Cell-penetrating Peptides, 
Trends in Pharmacological Sciences, Vol.21, No.3, (March 2000), pp. 99-103, PMID: 
10689363. 
Lovelock, J. & Bishop, M., (1959). Prevention of freezing damage to living cells by dimethyl 
sulfoxide. Nature, Vol.183, (May 1959), p. 1394, ISSN: 0022-202X. 
Lundberg, M. & Johansson, M. (2002). Positively Charged DNA-Binding Proteins Cause 
Apparent Cell Membrane Translocation, Biochemical and Biophysical Research 
Communications, Vol.291, No.1, (February 2002), pp. 367-71, PMID: 11846414. 
Mai, J.C., Shen, H., Watkins, S.C., Cheng, T. & Robbins, P.D. (2002). Efficiency of Protein 
Transduction is Cell Type-dependent and is Enhanced by Dextran Sulfate, Journal 
of Biological Chemistry, Vol.277, No.33, (August 2002), pp. 30208-18, PMID: 
12034749. 
Mathew, A.J., Baust, J.M., Van Buskirk, R.G. & Baust, J.G. (2004). Cell preservation in 
reparative and regenerative medicine: evolution of individualized solution 
composition, Tissue Engineering, Vol.10, No. 11, (November 2004), pp. 1662-71, 
PMID: 15684675. 
Miranda, A.F., Nette, G., Khan, S., Brockbank, K.G.M. & Schonberg, M. (1978). Alteration of 
myoblast phenotype by dimethyl sulfoxide, Proceedings of the National Academy of 
Sciences USA, Vol.75, (August 1978), pp. 3826-3830, PMID: 278996. 
Mondal, B. (2009). A simple method for cryopreservation of MDBK cells using trehalose and 
storage at −80°C, Cell and Tissue Banking, Vol.10, No.4, (November 2009), pp. 341-
344, PMID: 19381873. 
Morris, M.C., Robert-Hebmann, V., Chaloin, L., Mery, J., Heitz, F., Devaux, C., Goody, R.S. 
& Divita G. (1999). A New Potent HIV-1 reverse transcriptase Inhibitor. A Synthetic 
Peptide Derived from the Interface Subunit Domain, Journal of Biological Chemistry, 
Vol.274, No.35, (August 1999), pp. 24941-6, PMID: 10455170. 
Morris, M.C., Depollier, J., Mery, J., Heitz, F., Divita, G. (2001). A Peptide Carrier for the 
Delivery of Biologically Active Proteins into Mammalian Cells, Nature 
Biotechnology, Vol.19, No. 12, (December 2001), pp. 1173-76, PMID: 11731788. 
Mueller, L.P., Theurich, S., Christopeit, M., Grothe, W., Muetherig, A., Weber T, Guenther, S. 
& Behre, G. (2007). Neurotoxicity upon infusion of dimethyl sulfoxide-
cryopreserved peripheral blood stem cells in patients with and without pre-existing 
cerebral disease. European Journal of Haematology, Vol.78, No.6, (June 2007), pp. 527–
31, PMID: 17509106. 
Murgia, M., Pizzo, P., Steinberg, T.H. & Di Virgilio, F. (1992). Characterization of the 
Cytotoxic Effect of Extracellular ATP in J774 Mouse Macrophages, The Biochemical 
Journal, Vol.288, (December 1992), pp. 897-901, PMID: 1472003. 
Mussauer, H., Sukhorukov, V.L. & Zimmermann, U. (2001). Trehalose Improves Survival of 
Electrotransfected Mammalian Cells, Cytometry, Vol.45. No.3, (November 2001), pp. 
161-9, PMID: 11746084 
Nihei, O.K., Savino, W. & Alves, L.A. (2000). Procedures to Characterize and Study 
P2Z/P2X7 Purinoceptor: Flow Cytometry as a Promising Practical, Reliable Tool, 
www.intechopen.com
 Cryopreservation of Adherent Smooth Muscle and Endothelial Cells with Disaccharides 35 
Memorias do Instituto Oswaldo Cruz, Vol.95, No.3, (May 2000), pp. 415-28, 2000, 
PMID: 10800201. 
Oliver, A.E., Jamil, K., Crowe, J.H. & Tablin, F. (2004) Loading Human Mesenchymal Stem 
Cells with Trehalose by Fluid-Phase Endocytosis, Cell Preservation Technology, Vol.2, 
No.1, (2004) pp. 35-49. 
Otrock, Z.K., Beydoun, A., Barada, W.M., Masroujeh, R., Hourani, R. & Bazarbachi A. (2008). 
Transient global amnesia associated with the infusion of DMSO-cryopreserved 
autologous blood stem cells. Haematologica, Vol.93, No.3, (March 2008), pp. 36–7, 
PMID: 18310533. 
Polge, C., Smith, A.U. & Parkes A. (1949). Revival of spermatozoa after vitrification and de-
hydration at low temperatures. Nature. Vol.164, (October 1949), p. 666, ISSN: 0028-
0836 
Richard, J.P., Melikov, K., Vives, E., Ramos, C.,Birgit, V., Gait, M.J., Chernomordik, L.V. & 
Lebleu, B. (2003). Cell-penetrating Peptides: A Reevaluation of the Mechanism of 
Cellular Uptake, Journal of Biological Chemistry, Vol. 278, No.1, (January 2003), pp. 
585-90, PMID: 12411431. 
Rudolph, A.S. & Crowe, J.H. ( 1985). Membrane Stabilization During Freezing: The Role of 
Two Natural Cryoprotectants, Trehalose and Proline, Cryobiology, Vol.22, No.4, 
(August 1985), pp. 367-77, PMID: 4028782. 
Schlegel, P.G., Wölfl, M., Schick, J., Winkler, B. & Eyrich, M. (2009). Transient loss of 
consciousness in pediatric recipients of dimethyl sulfoxide (DMSO)-cryopreserved 
peripheral blood stem cells independent of morphine co-medication, Haematologica, 
Vol.94, No.10, (October 2009), pp. 1473-5, PMID: 19608681. 
Slade, L. & Levine, H. (1991). A food polymer science approach to structure-property 
relationships in aqueous food systems: non-equilibrium behavior of carbohydrate-
water systems, Advances in Experimental Medicine and Biology, Vol.302, (1991), pp. 
29-101, PMID: 17416335. 
Sosef, M.N., Baust, J.M., Sugimachi, K., Fowler, A., Tompkins, R.G. & Toner, M. (2005) 
Cryopreservation of isolated primary rate hepatocytes: enhanced survival and 
long-term hepatospecific function, Annals of Surgery,.Vol.241, No.1, (January 2005), 
pp. 125-33, PMID: 15622000. 
Taylor, M., Campbell, L., Rutledge, R., Brockbank, K. (2001). Comparison of Unisol with 
Euro-collins solution as a vehicle solution for cryoprotectants, Transplantation 
Proceedings, Vol.33, (February 2001), pp. 667-9, PMID : 11267013. 
Vives, E., Brodin, P. & Lebleu, B. (1997). A Truncated HIV-1 Tat Protein Basic Domain 
Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell 
Nucleus, Journal of Biological Chemistry, Vol.272, No.25, (June 1997), pp. 16010-17, 
PMID: 9188504. 
Walker, B., Braha, O., Cheley, S. & Bayley, H.(1995). An intermediate in the assembly of a 
pore-forming protein trapped with a genetically-engineered switch. Chemistry & 
Biology, Vol.2, No,2, (February 1995), pp. 99-105, PMID: 9383410. 
Zeng, X., Zhao, C., Wang, H., Li, S., Deng, Y. & Li, Z. (2010). Dimethyl Sulfoxide Decrease 
Type-I and –III Collagen Synthesis in Human Hepatic Stellate Cells and Human 
www.intechopen.com
 Current Frontiers in Cryopreservation 36
Foreskin Fibroblasts. Advanced Science Letters, Vol.3, No. 4, (December 2010), pp. 
496–499. 
www.intechopen.com
Current Frontiers in Cryopreservation
Edited by Prof. Igor Katkov
ISBN 978-953-51-0302-8
Hard cover, 462 pages
Publisher InTech
Published online 14, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Almost a decade has passed since the last textbook on the science of cryobiology, Life in the Frozen State,
was published. Recently, there have been some serious tectonic shifts in cryobiology which were perhaps not
seen on the surface but will have a profound effect on both the future of cryobiology and the development of
new cryopreservation methods. We feel that it is time to revise the previous paradigms and dogmas, discuss
the conceptually new cryobiological ideas, and introduce the recently emerged practical protocols for
cryopreservation. The present books, "Current Frontiers in Cryobiology" and "Current Frontiers in
Cryopreservation" will serve the purpose. This is a global effort by scientists from 27 countries from all
continents and we hope it will be interesting to a wide audience.
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